02282nas a2200265 4500008004100000245011100041210006900152260001400221300001200235490000700247520140000254653001701654653001601671653002301687653001501710653002701725100002501752700003001777700003101807700002601838700003101864700003501895700002701930856005901957 2024 eng d00aStandardization of Madhumukthi Kudineer Chooranum Using Pharmacognostic, Physicochemical and HPTLC Studies0 aStandardization of Madhumukthi Kudineer Chooranum Using Pharmaco cJune 2024 a531-5390 v163 a

Background: Siddha system of medicine is considered to be foremost among other systems of medicine. Many medicines are available in traditional systems for all kind of diseases. Most people show their interest towards Siddha medicine for non-communicable diseases especially for diabetes, hypertension, etc., Poly herbal formulations like Avarai kudineer has been authorized for prescription for Madhumegam. Madhumukthi Kudineer Chooranum (MKC) is one such medicine which has been found efficacious in Madhumegam (Diabetes mellitus). The current study is aimed at standardizing MKC employing pharmacognostic and chemical analyses with the aim of developing standards for quality control of this important medicine of Siddha. Materials and Methods: MKC was analyzed for pharmacognostic, physiochemical and HPTLC standards following standard procedures mentioned in Pharmacopoeias. Results: Macroscopy, powder microscopy was matched with the characters of these ingredients as reported in pharmacopoeias. The physicochemical standards were correlated with standards. TLC of MKC showed 10 spots under UV 254 nm, 13 spots under UV 366 nm and after spray with 5% vanillin sulphuric acid solution. Conclusion: The reported results will be supportive for standardization and future studies of MKC.

10aAntidiabetic10aAntioxidant10aKudineer chooranum10aMadhumegam10aPolyherbal formulation1 aBaskar, Rajamanickam1 aBharathkumar, Govindaraju1 aKumar, Koppala, Narayana S1 aShakila, Ramachandran1 aRajammal, Manekshah, Yovas1 aSelvapriya, Sikkal, Selvaraaju1 aDevi, Thangarasu, Hema uhttps://phcogres.com/article/2024/16/3/105530pres16363